Your Health, We Care
In the pursuit of health and recovery, rational use of drugs is a crucial part. Patients should be fully aware of the information about the drug, including but not limited to efficacy, dosage, and contraindications, before using any drug. Be sure to follow the doctor's guidance and do not increase or decrease the dose or change the drug at will, so as not to affect the efficacy or cause adverse reactions; Be aware of drug-drug interactions and avoid self-medication.
Capmatinib is indicated for the treatment of metastatic (spread) non-small cell ···【more】
Release date：2026-01-09Recommended：111
On February 11, 2020, Novartis announced that the U.S. Food and Drug Administrat···【more】
Release date：2026-01-09Recommended：86
On May 6, 2020, Novartis announced today that the U.S. Food and Drug Administrat···【more】
Release date：2026-01-09Recommended：105
Trametinib (Mekinist) is a targeted therapy indicated for the treatment of unres···【more】
Release date：2026-01-08Recommended：110
Ixazomib is a proteasome inhibitor, and its mechanism of action helps kill cance···【more】
Release date：2026-01-08Recommended：121
Ixazomib Citrate is approved for use in combination with lenalidomide and dexame···【more】
Release date：2026-01-08Recommended：105
Ixazomib has been approved by the U.S. Food and Drug Administration (FDA) for th···【more】
Release date：2026-01-08Recommended：119
Ixazomib is available in capsule dosage form and is a prescription-only medicine···【more】
Release date：2026-01-08Recommended：131
Ixazomib is classified as an antineoplastic agent (anticancer drug). Its mechani···【more】
Release date：2026-01-07Recommended：100
Ixazomib, in combination with lenalidomide and dexamethasone, is indicated for t···【more】
Release date：2026-01-07Recommended：87
Ixazomib is a proteasome inhibitor drug. Its mechanism of action is to prevent m···【more】
Release date：2026-01-07Recommended：102
Ixazomib is typically indicated for the treatment of multiple myeloma, a type of···【more】
Release date：2026-01-07Recommended：102
